No Confirmed Deal for Dick's Sporting Goods to Acquire Foot Locker

Published 1 hours agoDKS

No Confirmed Deal for Dick's Sporting Goods to Acquire Foot Locker

As of May 14, 2025, there is no confirmation that Dick's Sporting Goods is close to acquiring Foot Locker for approximately $2.3 billion. This speculation remains unfounded as no substantial information has emerged to support such a claim.

Foot Locker's most notable recent acquisition occurred in August 2021, when it purchased WSS (Eurostar, Inc.) for $750 million. Foot Locker has since steered its focus towards strengthening partnerships and improving store designs, aiming to enhance its customer experience. Notably, the company has been working closely with Nike and revamping its store formats to attract more customers.

Despite rumors of a possible acquisition, Foot Locker shows no public signs of imminent purchase by Dick's Sporting Goods. The company continues to prioritize its strategic relationships and operational enhancements rather than an acquisition strategy. Reuters and other reliable sources have not confirmed any such deal.

Share this article

Twitter Facebook LinkedIn

Recent Articles

FDA Approves Merck's Welireg for Rare Adrenal Tumors

FDA Approves Merck's Welireg for Rare Adrenal Tumors

4 minutes agoMRK

The U.S. Food and Drug Administration has approved the use of Merck's cancer drug, Welireg (belzutifan), for treating two rare types of adrenal gland tumors: pheochromocytoma and paraganglioma (PPGL). This marks Welireg as the first oral treatment approved for these tumors, providing a new and more convenient option for patients with these conditions. The expanded approval specifically targets patients aged 12 and older with metastatic or inoperable PPGL, according to Reuters. Clinical trials have shown that Welireg achieves a 20.6% objective response rate in treating these tumors, potentially improving patient care where previously, treatment options were limited primarily to surgery or palliative care. Before this approval, systemic options for managing PPGL were scarce. This new indication for Welireg aligns with its already existing approvals for cancers associated with Von Hippel-Lindau Disease and renal cell carcinoma, which contributed to $509 million in sales for Merck last year. This expansion signifies a meaningful step forward in addressing significant unmet medical needs for these rare conditions.

GeoPark Acquires Key Argentine Oil and Gas Assets

GeoPark Acquires Key Argentine Oil and Gas Assets

19 minutes agoGPRK

GeoPark Limited, a prominent oil and gas explorer in Latin America, announced the acquisition of non-operated working interests in four unconventional blocks in the Neuquén Basin, Argentina. This strategic expansion is set to enhance GeoPark's foothold in a prolific hydrocarbon region. The deal was signed on May 13, 2024, with Phoenix Global Resources, a subsidiary of Mercuria Energy Trading, and covers blocks in both Neuquén and Río Negro Provinces. The transaction involves a $190 million upfront payment for a total of 122,315 gross acres, which translates to 58,402 net acres for GeoPark. The company also committed to funding up to $113 million in exploratory commitments over two years and allocated $11 million for acquiring midstream capacity. Additionally, a $10 million bonus will be paid contingent upon the success of the Confluencia exploration campaign. Completion of the transaction is expected before the end of Q3 2024, pending necessary approvals. According to CEO Andrés Ocampo, the acquisition is poised to significantly boost GeoPark's production and reserves, potentially adding up to 6,500 net barrels of oil equivalent per day by 2024. Reuters noted that the inclusion of these assets will not only aid GeoPark's activity in Argentina but will also complement the company's existing operations in Colombia, Ecuador, and Brazil. This move underscores the company's strategic emphasis on developing unconventional resources in the renowned Vaca Muerta formation.

Harley-Davidson Defeats Investor's Proxy Challenge to Board

Harley-Davidson Defeats Investor's Proxy Challenge to Board

34 minutes agoHOG

Harley-Davidson has successfully navigated a proxy challenge initiated by activist investor H Partners, who holds a 9% stake in the company. The investor group sought to remove three directors from Harley-Davidson's board, including CEO Jochen Zeitz, due to concerns over declining sales and stock performance as reported by Reuters. In response, the board, led by Zeitz, urged shareholders to maintain continuity, emphasizing the need for strategic focus to address the company's challenges. Shareholders ultimately sided with the board, voting down the proposal and retaining the current members, which seemed to reassure the market. Following the vote, Harley-Davidson's stock experienced a slight increase, reflecting investor support for the leadership. Going forward, Harley-Davidson plans to tackle the issues raised by H Partners by launching new strategic initiatives aimed at boosting sales and expanding its customer base. The company's board appears to have bought some time to implement these plans without undergoing immediate leadership changes, maintaining stability in its management team.

Luminar Technologies Appoints Paul Ricci as New CEO

Luminar Technologies Appoints Paul Ricci as New CEO

49 minutes agoLAZR

Luminar Technologies has announced a significant leadership change with the appointment of Paul Ricci as CEO. This follows the resignation of Austin Russell, the company's founder, who stepped down amid an ethics inquiry. Austin Russell, who established Luminar in 2012, resigned from his top position as an ethics investigation looms. Luminar, known for its vision-based lidar and machine perception technologies for self-driving vehicles, went public in December 2020. This move had catapulted Russell into the spotlight as the world's youngest self-made billionaire. Reuters reported that as of May 14, 2025, the company's stock is trading at $4.76, reflecting a 5.52% uptick from the previous day's closing price. The new CEO, Paul Ricci, is expected to steer the company through this phase, addressing any hurdles presented by the current ethical challenges. Luminar's focus will likely remain on maintaining its leadership in lidar technology for autonomous vehicles, navigating both internal and market related demands effectively.